companydata.dkLEO PHARMA A/S
CVR: 56759514
Secondary names: LEO A/S, LEO INDUSTRIES A/S, LEO GROUP A/S
Previous names: LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB
LEO PHARMA A/S has shown a remarkable turnaround in financial health, achieving a significant revenue increase from 9.96 billion DKK in 2021 to 13.50 billion DKK in 2025, alongside a return to profitability with a profit of 2.49 billion DKK in 2025. Despite facing substantial losses in previous years, the company's equity has also improved, rising to 5.26 billion DKK in 2025 from a low of 1.95 billion DKK in 2022. Key strengths include its robust revenue growth and recovery in profit margins, although concerns remain regarding its past losses and overall debt management. With over 1,000 employees, LEO PHARMA holds a significant position in the pharmaceutical manufacturing industry, indicating resilience and potential for future growth.
AI-generated summary
Overview
Details
Purpose
Selskabets formål er at drive industrivirksomhed og handel.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 13.5 mia. | 2.5 mia. | 20.4 mia. | 5.3 mia. | 4104 | |
History
Ownership
Properties
(3)· 1 historic3 properties
Upgrade to Pro to see addresses, building data and ownership details
Management
Directors
Board
Production units (4)
Similar companies
Companies in the same industry and area